Avadel Pharmaceuticals plc (NASDAQ: AVDL)
$15.4700
+2.5600 ( +19.83% ) 5.1M
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
Market Data
Open
$15.4700
Previous close
$12.9100
Volume
5.1M
Market cap
$1.49B
Day range
$14.8500 - $16.7350
52 week range
$9.9800 - $19.0900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 04, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
8-k | 8K-related | 14 | Mar 04, 2024 |
10-k | Annual reports | 166 | Feb 29, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
8-k | 8K-related | 14 | Jan 08, 2024 |
4 | Insider transactions | 1 | Dec 29, 2023 |
8-k | 8K-related | 14 | Nov 08, 2023 |
10-q | Quarterly Reports | 73 | Nov 08, 2023 |
4 | Insider transactions | 1 | Sep 01, 2023 |